Literature DB >> 25093097

Relation of late gadolinium enhancement in cardiac magnetic resonance on the diastolic volume recovery of left ventricle with hypertrophic cardiomyopathy.

Xiaorong Chen1, Hongjie Hu1, Yue Qian1, Jiner Shu1.   

Abstract

OBJECTIVE: The purpose of the study was to investigate the influence of late gadolinium enhancement (LGE) on the diastolic volume recovery of left ventricle in patients with hypertrophic cardiomyopathy (HCM).
METHODS: Twenty-four HCM patients were studied through report-card 4.0. The presence or absence of late gadolinium enhancement was recorded according to a standardized methodology with a threshold value of six standard deviations above background. The LGE positive and negative groups were correlated to left ventricular end diastolic volume index (EDVI), left ventricular mass, left ventricular ejection fraction (EF), peak filling rate (PFR), peak ejecting rate (PER), normalized peak filling or ejecting rate (NPFR or NPER), time to peak filling or ejecting rate (TPFR or TPER), and diastolic volume recovery (DVR).
RESULTS: PFR, NPFR, SV, SVI, EF, CO, CI, FS in LGE positive group were lower than LGE negative group, DVR10-40, DVR100, end systolic volume (ESV), end systolic volume index (ESVI), ESD were higher in LGE positive group, and the differences were statistically significant. The average LGE mass (ROI, region of interest) was 20.78 g, about 13.67% of left ventricle mass in LGE positive HCM group. Pearson correlation was noted between the LGE percent (ROI%) and ESV (0.692, P<0.05), ROI% and EF (-0.718, P<0.05), ROI% and PFR (-0.534, P<0.05), DVR20-40 (0.547, 0.544, 0.906, P<0.05) etc. The correlation between ROI% and DVR40 was best (0.906, P<0.05), and the correlation between ROI% and ESVI, ROI% and EF were both bigger than 0.7, showed the correlation was good.
CONCLUSIONS: In addition to common quotas used to assess the structure and function of left ventricle in HCM, volume-time curve parameters may have potential to evaluate cardiac function in HCM. The correlation between DVR generated from volume-time curve with LGE was good, and may be a marker of effect of enhancement/scar tissue on diastolic function.

Entities:  

Keywords:  Hypertrophic cardiomyopathy (HCM); late gadolinium enhancement (LGE); magnetic resonance imaging; volume-time curve

Year:  2014        PMID: 25093097      PMCID: PMC4120178          DOI: 10.3978/j.issn.2072-1439.2014.06.37

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

Review 1.  Left intraventricular diastolic and systolic pressure gradients.

Authors:  Miguel Guerra; Francisco Sampaio; Cármen Brás-Silva; Adelino F Leite-Moreira
Journal:  Exp Biol Med (Maywood)       Date:  2011-11-23

2.  Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.

Authors:  Caitlin J Harrigan; Dana C Peters; C Michael Gibson; Barry J Maron; Warren J Manning; Martin S Maron; Evan Appelbaum
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

3.  Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Evan Appelbaum; Barry J Maron; Selcuk Adabag; Thomas H Hauser; John R Lesser; Tammy S Haas; Anne B Riley; Caitlin J Harrigan; Francesca N Delling; James E Udelson; C Michael Gibson; Warren J Manning; Martin S Maron
Journal:  Circ Cardiovasc Imaging       Date:  2011-12-01       Impact factor: 7.792

4.  Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance.

Authors:  Jeanette Schulz-Menger; Hassan Abdel-Aty; Andre Rudolph; Thomas Elgeti; Daniel Messroghli; Wolfgang Utz; Philipp Boyé; Steffen Bohl; Andreas Busjahn; Bernd Hamm; Rainer Dietz
Journal:  Eur J Heart Fail       Date:  2008-08-09       Impact factor: 15.534

5.  Automated segmentation of routine clinical cardiac magnetic resonance imaging for assessment of left ventricular diastolic dysfunction.

Authors:  Keigo Kawaji; Noel C F Codella; Martin R Prince; Christopher W Chu; Aqsa Shakoor; Troy M LaBounty; James K Min; Rajesh V Swaminathan; Richard B Devereux; Yi Wang; Jonathan W Weinsaft
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-21       Impact factor: 7.792

6.  Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging.

Authors:  Thananya Boonyasirinant; Prabhakar Rajiah; Randolph M Setser; Michael L Lieber; Harry M Lever; Milind Y Desai; Scott D Flamm
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

7.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  Lubna Choudhury; Heiko Mahrholdt; Anja Wagner; Kelly M Choi; Michael D Elliott; Francis J Klocke; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094

8.  Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.

Authors:  Giovanni Donato Aquaro; Piergiorgio Masci; Francesco Formisano; Andrea Barison; Elisabetta Strata; Alessandro Pingitore; Vincenzo Positano; Paolo Spirito; Massimo Lombardi
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778

9.  Impact of diastolic dysfunction severity on global left ventricular volumetric filling - assessment by automated segmentation of routine cine cardiovascular magnetic resonance.

Authors:  Dorinna D Mendoza; Noel C F Codella; Yi Wang; Martin R Prince; Sonia Sethi; Shant J Manoushagian; Keigo Kawaji; James K Min; Troy M LaBounty; Richard B Devereux; Jonathan W Weinsaft
Journal:  J Cardiovasc Magn Reson       Date:  2010-07-31       Impact factor: 5.364

Review 10.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

View more
  3 in total

1.  3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.

Authors:  Liang Yin; Hai-Yan Xu; Sui-Sheng Zheng; Ying Zhu; Jiang-Xi Xiao; Wei Zhou; Si-Si Yu; Liang-Geng Gong
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-13       Impact factor: 2.357

2.  Volume-time curve of cardiac magnetic resonance assessed left ventricular dysfunction in coronary artery disease patients with type 2 diabetes mellitus.

Authors:  Hua-Yan Xu; Zhi-Gang Yang; Ying-Kun Guo; Ke Shi; Xi Liu; Qin Zhang; Li Jiang; Lin-Jun Xie
Journal:  BMC Cardiovasc Disord       Date:  2017-06-05       Impact factor: 2.298

3.  Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  Michael Quail; Karl Grunseich; Lauren A Baldassarre; Hamid Mojibian; Mark A Marieb; Daniel Cornfeld; Aaron Soufer; Albert J Sinusas; Dana C Peters
Journal:  J Cardiovasc Magn Reson       Date:  2019-01-03       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.